Bone and joint health ingredient Market is predicted to reach USD 33.3 billion at a CAGR of 7.69% during the forecast period

Market Research Future (MRFR) has published a cooked research report on the “Global Bone and joint health ingredient Market” that contains information from 2023 to 2032. The Bone and joint health ingredient Market is estimated to register a CAGR of 7.69% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global Bone and joint health ingredient Market— DSM, BASF SE, Archer-Daniels-Midland Company (ADM), Glanbia PLC, Lonza Group, Stratum Nutrition, PharmaZen Limited, Darling Ingredients, Holista Collech, and Bioiberica S.A.U.

Market Highlights

The global Bone and joint health ingredient Market is accounted to register a CAGR of 7.69% during the forecast period and is estimated to reach USD 33.3 Billion by 2032.

The Bone and joint health ingredient Market refers to the market segment that focuses on the production, distribution, and consumption of ingredients and supplements that promote bone and joint health.

The Bone and joint health ingredient Market is driven by factors such as the growing aging population, increasing awareness about the importance of bone and joint health, and the rise in musculoskeletal disorders and conditions such as osteoporosis, arthritis, and joint pain.

Segment Analysis

The global Bone and joint health ingredient Market has been segmented based on type and application.

On the basis of type, the market is segmented into calcium, collagen, glucosamine, chondroitin and magnesium. Chondroitin sulfate is a component of cartilage and is often used in combination with glucosamine in joint health supplements. It helps maintain the integrity and elasticity of cartilage, promotes water retention in joint tissues, and supports joint lubrication.

Based on application, the market has been segmented into nutraceuticals & dietary supplements, food and beverages and pharmaceuticals. Food and beverages are likely to dominate the market over the forecast period, owing to the growing trend of functional food and beverage to support customers' active lifestyles.

Regional Analysis

The global Bone and joint health ingredient Market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Bone and joint health ingredient Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Bone and joint health ingredient Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Bone and joint health ingredient Market comprises of Middle East, Africa, and Latin America.

North America is a significant market for bone and joint health ingredients, driven by a large aging population and high prevalence of bone and joint disorders. The United States, in particular, has a well-developed market due to increased consumer awareness and a strong demand for dietary supplements.

Europe is another prominent market for bone and joint health ingredients. Countries like Germany, France, and the United Kingdom have a high demand for these ingredients due to a rising geriatric population and a focus on preventive healthcare.

The Asia Pacific region is experiencing significant growth in the Bone and joint health ingredient Market. Countries such as China, Japan, and India have large populations with increasing disposable income and a growing awareness of the importance of bone and joint health.

Furthermore, the rest of the world's Bone and joint health ingredient Market is divided into the Middle East, Africa, and Latin America. The Latin American market for bone and joint health ingredients is steadily expanding. Brazil, Mexico, and Argentina are key markets in the region, driven by an aging population and an increasing focus on health and wellness.

Key Findings of the Study

• The global Bone and joint health ingredient Market is expected to reach USD 33.3 Billion by 2032, at a CAGR of 7.69% during the forecast period.


• North America is a significant market for bone and joint health ingredients, driven by a large aging population and high prevalence of bone and joint disorders.


• Based on application, the market has been segmented into nutraceuticals & dietary supplements, food and beverages holding the largest market in 2022.

DSM, BASF SE, Archer-Daniels-Midland Company (ADM), Glanbia PLC, Lonza Group, Stratum Nutrition, PharmaZen Limited, Darling Ingredients, Holista Collech and Bioiberica S.A.U.